Resistance To BCR-ABL Targeting Drugs
In the case of Gleevec (Imatinib), which targets the BCR-ABL fusion gene in chronic myeloid leukemia, resistance often develops through a mutation that changes the shape of the binding site of the drug. Sequential application of drugs can lead to the sequential evolution of resistance mutations to each drug in turn.
Gleevec is not as selective as was originally thought. It turns out that it targets other tyrosine kinase genes and can be used to control gastrointestinal stromal tumors (GISTs) that are driven by mutations in c-KIT. However, patients with GIST sometimes relapse with additional mutations in c-KIT that make the cancer cells resistant to Gleevec.
Read more about this topic: Somatic Evolution In Cancer, Somatic Evolution in Therapeutic Resistance
Famous quotes containing the words resistance to, resistance and/or drugs:
“Growing older, I have lost the need to be political, which means, in this country, the need to be left. I am driven into grudging toleration of the Conservative Party because it is the party of non-politics, of resistance to politics.”
—Kingsley Amis (1922–1995)
“It is not the first duty of the novelist to provide blueprints for insurrection, or uplifting tales of successful resistance for the benefit of the opposition. The naming of what is there is what is important.”
—Ian McEwan (b. 1938)
“To possess your soul in patience, with all the skin and some of the flesh burnt off your face and hands, is a job for a boy compared with the pains of a man who has lived pretty long in the exhilarating world that drugs or strong waters seem to create and is trying to live now in the first bald desolation created by knocking them off.”
—C.E. (Charles Edward)